Health Condition 1: E063- Autoimmune thyroiditis Health Condition 2: C73- Malignant neoplasm of thyroid gland
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Consecutive patients undergoing thyroidectomy for benign or malignant thyroid diseases with any of the following histopathology 1. papillary thyroid carcinoma 2. thyroiditis and 3. both papillary thyroid carcinoma and thyroiditis
Exclusion criteria
Exclusion criteria: Patients with the following histopathology, namely Medullary thyroid carcinoma, Anaplastic thyroid carcinoma, Follicular thyroid carcinoma and benign thyroid histology other than thyroiditis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expression of BRAF mutation in papillary thyroid carcinoma and expression of RET/PTC rearrangement in Papillary thyroid carcinoma and coexistent thyroiditisTimepoint: Immediately after surgery- candidate genes on live thyroidectomy specimen 1 week post-surgery on formalin fixed paraffin embeded tissues 1 week post-surgery for IHC (immuno-histochemistry markers) | — |
Secondary
| Measure | Time frame |
|---|---|
| Expression of p63 and CK19 in immunohistochemistry of the surgical thyroid specimenTimepoint: 1 week post-surgery | — |
Countries
India
Contacts
Government Mohan Kumaramangalam Medical College